International Biotechnology Trust’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-62,000	Closed	-$1.31M	–	63
2017 Q1	$1.31M	Buy	+62,000	New	+$1.31M	0.5%	40